The Boryung Pharmaceutical’s Kanarb made a clinical procedure with the PMDA to challenge the Japanese market

Boryung Pharmaceutical (President Tae-hong Choi) took the first step to expand to Japan by holding a meeting to make a clinical procedure for an approval of Kanarb on the 19^th with the Pharmaceuticals and Medical Devices Agency (PMDA), the Department of Health and Human Services, Japan.

Although there have been cases where a domestic company conducts a clinical trial through an out-licensing o...